Lepu Medical Technology (Beijing) Co., Ltd. (SHE:300003)
China · Delayed Price · Currency is CNY 18.17
+0.02 (0.11%)
Nov 3, 2025, 2:45 PM CST
SHE:300003 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 426.33 | 246.94 | 1,258 | 2,204 | 1,719 | 1,802 | Upgrade |
Depreciation & Amortization | 560.04 | 560.04 | 513.56 | 488.47 | 448.74 | 388.21 | Upgrade |
Other Amortization | 96.42 | 96.42 | 90.22 | 79.16 | 72.83 | 54.92 | Upgrade |
Loss (Gain) From Sale of Assets | -2.99 | -2.99 | 7.87 | 1.69 | -19.9 | -2.29 | Upgrade |
Asset Writedown & Restructuring Costs | 119.71 | 119.71 | 36.59 | - | 2.39 | -434.02 | Upgrade |
Loss (Gain) From Sale of Investments | 89.29 | 89.29 | 13.44 | 70.91 | 367.54 | 153.17 | Upgrade |
Provision & Write-off of Bad Debts | 50.36 | 50.36 | 26.13 | 24.45 | 20.76 | 38.17 | Upgrade |
Other Operating Activities | 701.16 | 290.93 | 337.04 | 278.83 | 308.15 | 349.86 | Upgrade |
Change in Accounts Receivable | -62.84 | -62.84 | 3.22 | -665.07 | 42.85 | -32.72 | Upgrade |
Change in Inventory | 206.28 | 206.28 | -251.01 | -386.7 | -494.73 | -422.85 | Upgrade |
Change in Accounts Payable | -688.65 | -688.65 | -982 | 710.12 | 660.39 | 165.53 | Upgrade |
Operating Cash Flow | 1,324 | 734.64 | 990.36 | 2,791 | 3,062 | 2,090 | Upgrade |
Operating Cash Flow Growth | 63.56% | -25.82% | -64.51% | -8.86% | 46.53% | 5.00% | Upgrade |
Capital Expenditures | -605.75 | -658.82 | -844.67 | -905.22 | -984.4 | -600.15 | Upgrade |
Sale of Property, Plant & Equipment | 1.38 | 30.03 | 8.52 | 2.55 | 2.09 | 44.66 | Upgrade |
Cash Acquisitions | 3.27 | -21.82 | -344.92 | -3.1 | -453.01 | -112.94 | Upgrade |
Divestitures | 4.51 | 4.42 | -48.08 | - | 0.15 | 3.25 | Upgrade |
Investment in Securities | -233.4 | -237.88 | -65.41 | -648.89 | 129.18 | 17.77 | Upgrade |
Other Investing Activities | 285.4 | 73.66 | -428.32 | 0.47 | 533.27 | -210.35 | Upgrade |
Investing Cash Flow | -478.06 | -743.9 | -1,886 | -1,599 | -860.46 | -695.45 | Upgrade |
Long-Term Debt Issued | - | 3,168 | 2,694 | 1,828 | 3,745 | 4,699 | Upgrade |
Long-Term Debt Repaid | - | -2,352 | -2,320 | -2,601 | -4,338 | -4,798 | Upgrade |
Total Debt Repaid | -1,910 | -2,352 | -2,320 | -2,601 | -4,338 | -4,798 | Upgrade |
Net Debt Issued (Repaid) | -67.46 | 815.96 | 373.41 | -772.86 | -592.54 | -98.91 | Upgrade |
Issuance of Common Stock | - | - | - | 1,533 | - | - | Upgrade |
Repurchase of Common Stock | -177.43 | -177.43 | -75.24 | -245.91 | -109.91 | - | Upgrade |
Common Dividends Paid | -679.9 | -990.89 | -768.66 | -635.65 | -587.04 | -598.4 | Upgrade |
Other Financing Activities | 433.97 | -132.86 | 177.57 | 534.17 | 392.09 | -66.12 | Upgrade |
Financing Cash Flow | -490.82 | -485.22 | -292.92 | 412.75 | -897.41 | -763.44 | Upgrade |
Foreign Exchange Rate Adjustments | 6.43 | 8.92 | -20.59 | 21.13 | -11.31 | -31.23 | Upgrade |
Net Cash Flow | 361.82 | -485.56 | -1,209 | 1,625 | 1,293 | 599.58 | Upgrade |
Free Cash Flow | 718.52 | 75.82 | 145.69 | 1,885 | 2,078 | 1,490 | Upgrade |
Free Cash Flow Growth | 351.97% | -47.96% | -92.27% | -9.25% | 39.48% | 4.37% | Upgrade |
Free Cash Flow Margin | 11.48% | 1.24% | 1.83% | 17.77% | 19.49% | 18.53% | Upgrade |
Free Cash Flow Per Share | 0.39 | 0.04 | 0.08 | 1.04 | 1.15 | 0.84 | Upgrade |
Cash Income Tax Paid | 651.26 | 775.28 | 970.56 | 962.96 | 725.21 | 831.87 | Upgrade |
Levered Free Cash Flow | 42.03 | 72.98 | -338.09 | 1,603 | 1,479 | 848.37 | Upgrade |
Unlevered Free Cash Flow | 158.62 | 186.1 | -231.43 | 1,721 | 1,622 | 1,016 | Upgrade |
Change in Working Capital | -716.06 | -716.06 | -1,293 | -356.6 | 142.15 | -260.25 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.